|
Our Sofia office is part of our continuing commitment to expand our presence in Central and Eastern Europe to further meet the patient recruitment needs of our pharmaceutical customers.
From our Sofia operations we’re able to cover the South East of Europe – Bulgaria, Serbia and Montenegro, Macedonia, Croatia, Slovenia, Greece and Turkey. With a combined population of approximately 105 million, this emerging region has become the most attractive one for conducting clinical trials during the last five years, in almost every indication and every phase of drug development.
Our Sofia office provides comprehensive Phase II–IV clinical services such as protocol feasibility and site selection, regulatory document collection, monitoring and site management, project management, resourcing, post marketing surveillance and health economic/outcomes research services. |
